(Credit: Unsplash)This article is published in association with European Investment Bank. EIB provides €20 million venture debt financing to Finnish life-science company Aiforia, to further develop its AI powered platform used in digital tissue analysis. Aiforia’s deep learning artificial intelligence (AI) solutions can revolutionise diagnostic capabilities in image analysis, also enabling new medical discoveries. TheEuropean Investment Bank (EIB)has signed a €20 million venture debt financing agreement with Finnish life-science technology innovator Aiforia. Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology.